Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona C McKay

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|February 6, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of diseaseGrant P Parnell, Prudence N Gatt, Malgorzata Krupa, et al.
Infection and Immunity|December 23, 2003
Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infectionFiona C McKay, Jason D McArthur, Martina L Sanderson-Smith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2006
Trigger for group A streptococcal M1T1 invasive diseaseJason N Cole, Jason D McArthur, Fiona C McKay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by seasonGrant P Parnell, Prudence N Gatt, Fiona C McKay, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapiesFiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Human Molecular Genetics|March 2, 2010
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesisKaushal S Gandhi, Fiona C McKay, Mathew Cox, et al.
Plos One|December 15, 2010
A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosisCarlos Riveros, Drew Mellor, Kaushal S Gandhi, et al.
JAMA Neurology|March 7, 2018
Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse ModelRebecca K Sheean, Fiona C McKay, Erika Cretney, et al.
Journal of Innate Immunity|September 4, 2010
Parameters governing invasive disease propensity of non-M1 serotype group A streptococciPeter G Maamary, Martina L Sanderson-Smith, Ramy K Aziz, et al.
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|February 6, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of diseaseGrant P Parnell, Prudence N Gatt, Malgorzata Krupa, et al.
Infection and Immunity|December 23, 2003
Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infectionFiona C McKay, Jason D McArthur, Martina L Sanderson-Smith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2006
Trigger for group A streptococcal M1T1 invasive diseaseJason N Cole, Jason D McArthur, Fiona C McKay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by seasonGrant P Parnell, Prudence N Gatt, Fiona C McKay, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapiesFiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Human Molecular Genetics|March 2, 2010
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesisKaushal S Gandhi, Fiona C McKay, Mathew Cox, et al.
Plos One|December 15, 2010
A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosisCarlos Riveros, Drew Mellor, Kaushal S Gandhi, et al.
JAMA Neurology|March 7, 2018
Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse ModelRebecca K Sheean, Fiona C McKay, Erika Cretney, et al.
Journal of Innate Immunity|September 4, 2010
Parameters governing invasive disease propensity of non-M1 serotype group A streptococciPeter G Maamary, Martina L Sanderson-Smith, Ramy K Aziz, et al.
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
Pageof 3